North America Fusion Biopsy Market Size

North America Fusion Biopsy Market Size, Growth & Analysis 2026

North America Fusion Biopsy Market By End Use (Diagnostic centers, Hospitals and Ambulatory care centers), By Route (Transperineal and Transrectal), By Country, Industry Analysis and Forecast, 2020 - 2026

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Published Date : September-2020 | Number of Pages : 52 | Format : PDF


Get in-depth analysis of the COVID-19 impact on the North America Fusion Biopsy Market

Market Report Description

The North America Fusion Biopsy Market would witness market growth of 10.7% CAGR during the forecast period (2020-2026). A Fusion biopsy system combines MRI ultrasound along with biopsy system for a better view. Fusion biopsy is also termed as fusion guided biopsy. Moreover, biopsy infers taking the tissue sample from the body then examines the report and detect it in the best possible manner. When test previously done in case of any prostrate related problems and if that test shows an anomaly in certain areas of the sample; then doctors recommend for biopsy.

The factors that drive the growth of the Fusion Biopsy System Market comprise the rising demand, increasing cancer disorders, changes brought into the standard of living, a more sedentary lifestyle, and at the same time increasing awareness among people. Fusion Biopsy System Market is further characterized based on geography and applications. On the basis of End Use, Fusion Biopsy System Market is categorized into Hospitals, Diagnostic Centers, and Ambulatory Surgical Center (ASCs).

The government initiatives are also increasing in terms of spreading awareness, funding research, and conducting mass screening programs that are related to prostate cancer therefore they are predicted to play a vital role in the growth of the fusion biopsy market. For example, the U.S. federal government is investing millions of dollars annually in prostate cancer research from the Prostate Cancer Research Program (PCRP), and the National Institute of Health (NIH). The venture is made to progress the advancement in prostate cancer care, its diagnostic and treatment technologies.

Based on End Use, the market is segmented into Diagnostic centers, Hospitals and Ambulatory care centers. Based on Route, the market is segmented into Transperineal and Transrectal. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

Free Valuable Insights: Fusion Biopsy Market in North America is expected to register a CAGR of 10.7% during the forecast period (2020-2026)

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Hitachi, Ltd., Baxter International, Inc. (MedCom), Esaote SpA, Eigen, KOELIS, Inc., Focal Healthcare, Inc. and UC-Care Medical Systems Ltd.

Scope of the North America Fusion Biopsy Market Analysis

Market Segmentation:

By End Use

  • Diagnostic centers
  • Hospitals
  • Ambulatory care centers

By Route

  • Transperineal
  • Transrectal

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled

  • Koninklijke Philips N.V.
  • Hitachi, Ltd.
  • Baxter International, Inc. (MedCom)
  • Esaote SpA
  • Eigen
  • KOELIS, Inc.
  • Focal Healthcare, Inc.
  • UC-Care Medical Systems Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Fusion Biopsy Market Related Reports:

Global Market

Europe Market

Asia Pacific Market

LAMEA Market

Purchase Report


Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities